Patents by Inventor Hirotaka Kanzaki

Hirotaka Kanzaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB
    Publication number: 20210085649
    Abstract: The invention provides methods and agents that modulate RelA activity. These methods and modulators of RelA activity can be used to treat cancer progression of basal-like breast cancer, such as triple-negative breast cancer.
    Type: Application
    Filed: December 1, 2020
    Publication date: March 25, 2021
    Applicant: Cedars-Sinai Medical Center
    Inventors: Ramachandran MURALI, Hirotaka KANZAKI
  • Methods and use of compounds that bind to RelA of NF-kB
    Patent number: 10881641
    Abstract: The invention provides methods and agents that modulate RelA activity. These methods and modulators of RelA activity can be used to treat cancer progression of basal-like breast cancer, such as triple-negative breast cancer.
    Type: Grant
    Filed: November 30, 2017
    Date of Patent: January 5, 2021
    Assignee: CEDARS-SINAI MEDICAL CENTER
    Inventors: Ramachandran Murali, Hirotaka Kanzaki
  • METHODS AND USE OF COMPOUNDS THAT BIND TO RELA OF NF-KB
    Publication number: 20180078528
    Abstract: The invention provides methods and agents that modulate RelA activity. These methods and modulators of RelA activity can be used to treat cancer progression of basal-like breast cancer, such as triple-negative breast cancer.
    Type: Application
    Filed: November 30, 2017
    Publication date: March 22, 2018
    Applicant: Cedars-Sinai Medical Center
    Inventors: Ramachandran Murali, Hirotaka Kanzaki